Point State Capital LP Abb Vie Inc. Call Options Transaction History

Point State Capital LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $267 Million - $332 Million	-2,025,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $154 Million - $195 Million	1,436,000 Added 243.8%	2,025,000 $274 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $46.7 Million - $53 Million	439,000 Added 292.67%	589,000 $63.5 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $15.8 Million - $17.6 Million	150,000 New	150,000 $16.9 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.